Evidence map›Paper›PMID 42530367›Full record

ArticleAmerican journal of hypertension2026

Increased excitability of renal sensory neurons by vasopressin in male and female Sprague-Dawley rats.

Sebastien Hayoz, Christopher T Banek

Abstract read
In one paragraph

Article in American journal of hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sebastien HayozDepartment of Surgery, Division of Autonomic Neuromodulation, University of Minnesota, Minneapolis, MN, United States.
Christopher T BanekDepartment of Surgery, Division of Autonomic Neuromodulation, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0002-9861-1402

Funding

Renal Denervation to Treat Polycystic Kidney Disease: Mechanisms and MediatorsR01DK135573 · NIDDK · UNIVERSITY OF MINNESOTA · PI Christopher T Banek · 2024 to 2026
$1.8M
NIDDK NIH HHS R01 DK135573NIDDK NIH HHS R01DK135573Polycystic Kidney Disease Foundation Research 1022534
6 · The paper itself

Abstract

backgroundPreclinical models of cardiovascular and kidney diseases, such as hypertension and polycystic kidney disease (PKD), are associated with increased vasopressin (AVP) and increased renal afferent nerve activity (ARNA). We have also shown that ablation of renal sensory nerves can mitigate HTN and PKD progression in preclinical models. Yet, the underlying cause of elevated renal sensory nerve activity in disease remains unclear, and the role of vasopressin remains untested. Therefore, we hypothesized that AVP would increase the excitability of renal-specific dorsal root ganglia neurons (rDRGN) in both male and female rats.

methodsTo address this hypothesis, rDRGN were isolated from both male and female Sprague-Dawley (SD) rats and cell excitability changes with AVP were measured by whole-cell patch clamp in current-clamp mode. Excitability was quantified by mean action potential (AP) frequency, rheobase, and multi-firing threshold. Dose-dependent responses to AVP (10-12-10-6 M) were measured and compared to vehicle (saline).

resultsCell excitability was increased by AVP in both male and female cells, increasing AP frequency and lowering rheobase and multi-firing threshold. The effective excitatory range of AVP was 10-10-10-6 M in female cells, and 10-8-10-6 M in males.

conclusionsThese experiments support our initial hypothesis that AVP would directly increase rDRGN excitability. This excitatory effect may support a novel role through which peripheral sensory nerves interact with and respond to AVP. In turn, this AVP-ARNA interaction may contribute to elevated peripheral sensory nerve activity and disease progression where AVP is elevated, such as hypertension and PKD.

Indexed as

Ganglia, SpinalKidneySensory Receptor CellsVasopressinsAction PotentialsAnimalsDose-Response Relationship, DrugFemaleMaleNeurons, AfferentRatsRats, Sprague-DawleyVasopressinsdorsal root ganglionelectrophysiologyhypertensionpatch clamppolycystic kidney diseaserenal nervessensory nervesvasopressin

Identifiers

PMID42530367
PMCPMC13662406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.